SEC Form 4 · accession 0001144204-15-072634
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank R. Oakes
Officer — President, CEO & Director · Director
Period of report
Dec 22, 2015
Accepted (ET)
Dec 23, 2015 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540159
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF1 | Dec 22, 2015 | M | 4,000 | $2.86 | A | 197,965 | D | |
| Common Shares, without par value | Dec 22, 2015 | G | 9,000 | $0.00 | D | 188,965 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Exercise of the security was transacted in Canadian currency and converted to U.S. currency.